20 LATEST RESOURCES (120 INDEXED)
Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine · February 2024
Articles
Annals of General Psychiatry
Longitudinal Changes in Habitual Physical Activity in Adult People with Cystic Fibrosis in the Presence or Absence of Treatment with Elexacaftor/Tezacaftor/Ivacaftor · February 2024
Articles
Frontiers in Sports and Active Living
The Real-World Effectiveness of Fluvoxamine Therapy in Mild to Moderate COVID-19 Patients; A Historical Cohort Study (Fluvoxa Trial) · October 2023
Articles
Journal of Infection and Public Health
Effects of Smoking Cessation on Plasma Clozapine Concentrations in Male Patients with Schizophrenia during the COVID-19 Pandemic · September 2023
Articles
Frontiers in Psychiatry
Potential Pharmacokinetic Interactions with Concurrent Use of Herbal Medicines and a Ritonavir-Boosted COVID-19 Protease Inhibitor in Low and Middle-Income Countries · July 2023
Articles
Frontiers in Pharmacology
The Impacts of Clozapine Use on the Risk and Outcomes of COVID-19 Disease in Patients with Schizophrenia · May 2023
Articles
NCBI>Archives of Neuropsychiatry
“Sign Me Up”: A Qualitative Study of Video Observed Therapy (VOT) for Patients Receiving Expedited Methadone Take-Homes during the COVID-19 Pandemic · March 2023
Articles
Addiction Science and Clinical Practice
Overview of the Potential Use of Fluvoxamine for COVID-19 and Long COVID · March 2023
Articles
Discover Mental Health
Effects of Ipratropium Bromide Combined with Traditional Chinese Medicine Intervention on the Pulmonary Function and Psychological Status of Patients with Chronic Obstructive Pulmonary Disease · February 2023
Articles
Evidence-Based Complementary and Alternative Medicine
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial · January 2023
Multimedia (Interviews-Authors)
Journal of the American Medical Association
Successful Use of Ketamine to Treat Severe Depression with Suicidality Post-COVID-19 – A Case Report · December 2022
Articles
Psychiatry Research Case Reports
Neutropenia After the Coadministration of Clozapine and Nirmatrelvir-Ritonavir in a Patient with SARS-CoV-2 Infection: A Case Report with a Literature Review · December 2022
Articles
Frontiers in Psychiatry
Impact of Fluvoxamine on Outpatient Treatment of COVID-19 in Honduras in a Prospective Observational Real-World Study · November 2022
Articles
Frontiers in Pharmacology
Opportunities and Challenges: Hepatitis C Testing and Treatment Access Experiences among People in Methadone and Buprenorphine Treatment during COVID-19, Arizona, 2021 · November 2022
Articles
AJPM Focus
Effect of Fluvoxamine on Outcomes of Nonhospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis · October 2022
Articles
Journal of Infection and Public Health
Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder: A Real-World Case-Control Study · October 2022
Articles
Primary Care Companion for CNS Disorders
Methadone and Buprenorphine-Related Deaths among People Prescribed and Not Prescribed Opioid Agonist Therapy during the COVID-19 Pandemic in England · October 2022
Articles
International Journal of Drug Policy
The Risk of COVID-19 in Patients of Chronic Kidney Disease with Cognitive Dysfunction Like Alzheimer Disease: A Perspective on Erythropoietin as a Potential Adjuvant Therapy · October 2022
Articles
International Journal of Nutrition, Pharmacology, Neurological Diseases
Fluvoxamine for the Treatment of COVID-19 · September 2022
Articles
Cochrane Database of Systematic Reviews
Possible Clinical and Pharmacogenetic Predictors of the Efficacy and Safety of Carbamazepine in Post-COVID-19 Depression · September 2022
Articles
NCBI>Psychiatria Danubina